Synergic Medical Technologies
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Synergic Medical Technologies sits in the upper quartile of US sponsors by registered trial count (#3,661 of 15,742 sponsors by registered trial count).
Synergic Medical Technologies: 3 sponsored US clinical trials, 2 recruiting.
Synergic Medical Technologies sponsors 3 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting. The most-studied condition in this pipeline is Parkinson's Disease, with 1 trials.
Upper-quartile sponsor footprint
Synergic Medical Technologies sits in the upper quartile of the sponsor corpus (#3,661 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
3 total, page 1 of 1
Vibrotactile Coordinated Reset: a Non-invasive Treatment for Parkinson's Disease 2
NCT05881460
Patterned Multichannel Vibrotactile Stimulation for the Longitudinal Treatment of Moderate Stage Parkinson's Disease
NCT05830110
Vibrotactile Coordinated Reset: A Non-invasive Treatment for Parkinson's Disease
NCT04877015
Therapeutic Areas
What is open in the Synergic Medical Technologies pipeline
2 recruiting of 3 indexed (67% open).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Parkinson's Disease (1 trial), 1 other listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Synergic Medical Technologies: open-pipeline peers nationwide
Peers matched on 3 registered trials and 67% open enrollment, not the therapeutic-area sidebar.
Synergic Medical Technologies sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 3 trials (± recruiting share)
- 10xBio · 3 trials · 0% recruiting
- 22nd Century Group · 3 trials · 0% recruiting
- AA Secord · 3 trials · 0% recruiting
- AAADRS Clinical Research Center · 3 trials · 0% recruiting
Sponsors near 67% open enrollment (± trial volume)
- Abbisko Therapeutics Co · 67% recruiting · 6 trials
- ABL Bio · 67% recruiting · 3 trials
- Accelerated Cure Project for Multiple Sclerosis · 67% recruiting · 3 trials
- Advanced Reconstructive Surgery Alliance · 67% recruiting · 3 trials
Related
What to do with this Synergic Medical Technologies page
3 registered trials is a research-attention snapshot, not an endorsement of Synergic Medical Technologies or any single study.
- 2 of Synergic Medical Technologies's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Parkinson's Disease is the condition Synergic Medical Technologies studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Parkinson's Disease trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Synergic Medical Technologies pipeline card: 3 registered trials from official public datasets.Report a data error.